Management of Metastatic Prostate Cancer
Prostate cancer is the most common cancer in men in the United States and will affect 1 in every 6 men 65 years and older. Fortunately, when detected early, it is very treatable. Long-term follow-up of patients with treated prostate cancer is usually performed by primary care providers.
Category
  • Oncology
Format
  • Online CME Courses
  • Webinar recorded
Credits
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Attendance
Modern Management of Neuroendocrine Tumors
Neuroendocrine neoplasms are rare tumors that display marked heterogeneity with varying natural history, biological behavior, response to therapy and prognosis. Their management is complex and often diagnosed late due to lack of specific symptoms during the early stages of the disease.
Category
  • Oncology
Format
  • Online CME Courses
  • Webinar recorded
Credits
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Attendance
Approaches to Leukemia Care
Leukemia is a heterogeneous group of hematologic malignancies that arise from the dysfunctional proliferation of developing leukocytes. It is classified as either acute or chronic and as myelocytic or lymphocytic. Treatment depends on the type of leukemia but generally involves chemotherapy.
Category
  • Hematology
  • Oncology
Format
  • Online CME Courses
  • Webinar recorded
Credits
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Attendance
Current Approaches in the Treatment of Advanced Melanoma
Melanoma is the third most common cutaneous malignancy after basal cell carcinoma and squamous cell carcinoma.
Category
  • Dermatology
  • Oncology
Format
  • Online CME Courses
  • Webinar recorded
Credits
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Attendance